Qura Therapeutics will develop HIV treatments in partnership with University of North Carolina at Chapel Hill, a venture in which it is investing $20m.

Security software provider Avast has invested $22m in Jumpshot, which it acquired two years ago when the marketing analytics company focused on online security.

Green Cross and Posco Capital co-led a $7.5m series B-2 round for the Takeda-backed regenerative medicine developer, which has now raised almost $40m in total.

The partnership, formed to develop immuno-oncology drugs, will include a $30m equity investment in BioNTech subsidiary Cell & Gene Therapies.

Novartis and Cleveland Clinic returned to fund the medical device maker's series D round, which increased its overall funding to $95m.

Genome editing technology developer Precision BioSciences has raised $25.6m in funding from backers including Amgen and Baxter's corporate venturing units.

Salesforce Ventures has contributed to a round that will fund an expansion of the big data analytics company's team and the development of its technology.

Audi joined the mobile connectivity platform's existing corporate investors, Qualcomm and Sierra Wireless, to help fund a $20.3m round.

The aerospace company was among the investors in a $25m series B round for Cybereason, which plans to use the cash to double its workforce.

The SoftBank-backed snack delivery service took its total funding to almost $60m in a round led by Rocket Internet-affiliated fund Global Founders Capital.